Ausgabe 10/2016
Inhalt (14 Artikel)
Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)
The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis
James C. Needell, Danny Zipris
Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis
Sherman S. Leung, Josephine M. Forbes, Danielle J. Borg
Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)
Biomarkers of β-Cell Stress and Death in Type 1 Diabetes
Raghavendra G. Mirmira, Emily K. Sims, Farooq Syed, Carmella Evans-Molina
Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors)
Taking Telemedicine to the Next Level in Diabetes Population Management: a Review of the Endo ECHO Model
Matthew F. Bouchonville, Margaret M. Paul, John Billings, Jessica B. Kirk, Sanjeev Arora
Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors)
Academic Detailing in Diabetes: Using Outreach Education to Improve the Quality of Care
Michael A. Fischer
Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)
Fenofibrate and Diabetic Retinopathy
Jared E. Knickelbein, Akshar B. Abbott, Emily Y. Chew
Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors)
Surgery for Diabetic Eye Complications
María H. Berrocal, Luis A. Acaba, Alexandra Acaba
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
Dragana Lovre, Wynn Htun, Carly Carrion, Vivian A. Fonseca
Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors)
SGLT2 Inhibitors: Benefit/Risk Balance
André J. Scheen
Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors)
Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination
Rudruidee Karnchanasorn, Horng-Yih Ou, James Lin, Lee-Ming Chuang, Ken C. Chiu
Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors)
Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk
Katie A. Meyer, Brian J. Bennett
Diabetes Epidemiology (N Maruthur, Section Editor)
Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes
Scott J. Pilla, Amy Q. Quan, Emily L. Germain-Lee, David B. Hellmann, Nestoras N. Mathioudakis
Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor)
Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes
Kimber M. Simmons, Peter A. Gottlieb, Aaron W. Michels
Obesity (J McCaffery, Section Editor)
Salivary Amylase: Digestion and Metabolic Syndrome
Catherine Peyrot des Gachons, Paul A. S. Breslin